Acasă › Obezitate › South Carolina

Studii clinice pentru Obezitate în South Carolina

45 studii pentru Obezitate caută participanți în South Carolina.

Orașe în South Carolina

Text oficial al studiului (în engleză)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Monroe Biomedical Research - Charleston, North Charleston

În curs de recrutareFaza 2

Vârste de 18 ani și peste · Toate sexele · Actualizat 30 sept. 2026 · NCT07783802

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Spartanburg Medical Research, Spartanburg

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 30 sept. 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Prisma Health-Ped Endo, Greenville
Coastal Carolina Research Ctr, North Charleston

În curs de recrutareFaza 3

Vârste de la 8 la 18 · Toate sexele · Actualizat 30 sept. 2026 · NCT07253285

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Tribe Clinical Research, Greenville

În curs de recrutareFaza 2

Vârste de 18 ani și peste · Toate sexele · Actualizat 29 sept. 2026 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Medical Uni of SC Charleston, Charleston
Coastal Carolina Research Ctr, North Charleston
Hillcrest Clinical Research, Simpsonville
și încă 1

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Medical University Of South Carolina, Charleston
Hillcrest Clinical Research, Simpsonville
Spartanburg Medical Research, Spartanburg

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07668414

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Gastroenterology Associates - Patewood, Greenville

În curs de recrutareFaza 3

Vârste de la 18 la 70 · Toate sexele · Actualizat 24 sept. 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Coastal Pediatric Associates, Charleston
Medical University of South Carolina Children Hospital - PIN, Charleston

În curs de recrutareFaza 3

Vârste de la 6 la 17 · Toate sexele · Actualizat 24 sept. 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Gastroenterology Associates - Patewood, Greenville

În curs de recrutareFaza 3

Vârste de la 18 la 70 · Toate sexele · Actualizat 24 sept. 2026 · NCT06937086

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Medical Uni of SC Charleston, Charleston
Coastal Carolina Research Ctr, North Charleston
Hillcrest Clinical Research, Simpsonville

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 24 sept. 2026 · NCT07339423

Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy

University South Carolina, Columbia

În curs de recrutare

Vârste de la 18 la 65 · Toate sexele · Actualizat 23 sept. 2026 · NCT07518407

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Accellacare - Mt Pleasant, Mt. Pleasant

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Trial Management Associates, Myrtle Beach

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Bogan Sleep Consultants, Columbia

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Accellacare Charleston, Mt. Pleasant

În curs de recrutareFaza 3

Vârste de la 45 la 99 · Toate sexele · Actualizat 22 sept. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Tribe Clinical Research, LLC, Greenville
Accellacare - Mt Pleasant, Mt. Pleasant

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Tribe Clinical Research, LLC, Greenville

În curs de recrutareFaza 2

Vârste de la 18 la 75 · Toate sexele · Actualizat 22 sept. 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Bluffton
AURORA-1 Clinical Site, Clemson
AURORA-1 Clinical Site, Columbia
și încă 1

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 16 sept. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Bluffton
AURORA-2 Clinical Site, Clemson
AURORA-2 Clinical Site, Columbia
și încă 1

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 16 sept. 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Coastal Carolina Research Center, North Charleston

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 14 sept. 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Trial Management Associates, Myrtle Beach

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 14 sept. 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Greer

În curs de recrutareFaza 3Voluntari sănătoși bineveniți

Vârste de la 18 la 79 · Toate sexele · Actualizat 11 sept. 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Spartanburg Medical Research, Spartanburg

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 9 sept. 2026 · NCT07770841

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Bogan Sleep Consultants, LLC, Columbia

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 9 sept. 2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Tribe Clinical Research, LLC, Greenville

În curs de recrutareFaza 2

Vârste de la 18 la 75 · Toate sexele · Actualizat 8 sept. 2026 · NCT06143956

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Columbia Dermatology & Aesthetics, Columbia

În curs de recrutareFaza 4

Vârste de 18 ani și peste · Toate sexele · Actualizat 4 sept. 2026 · NCT06857942

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Coastal Carolina Res Ctr, North Charleston

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 4 sept. 2026 · NCT07745504

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Spartanburg

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 3 sept. 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Tribe Clinical Research LLC Dba Mountain View Clinical Research, Greenville

În curs de recrutareFaza 3

Vârste de la 18 la 99 · Toate sexele · Actualizat 3 sept. 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Mauldin

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 3 sept. 2026 · NCT07284875

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Kailera Clinical Site, North Charleston
Kailera Clinical Site, Spartanburg

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 1 sept. 2026 · NCT07284979

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Med. Uni. of SC Ashley River T, Charleston
Piedmont Research Partners, LLC, Fort Mill

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 18 aug. 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Greer

În curs de recrutareFaza 3

Vârste de la 18 la 79 · Toate sexele · Actualizat 10 aug. 2026 · NCT07654361

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Tribe Clinical Research, Greenville
Coastal Carolina Research Center_North Charleston, North Charleston

În curs de recrutareFaza 2

Vârste de la 18 la 80 · Toate sexele · Actualizat 22 iul. 2026 · NCT07477704

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Coastal Carolina Res Ctr, North Charleston

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 9 iul. 2026 · NCT07481630

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Coastal Carolina Research Ctr, North Charleston

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 iun. 2026 · NCT07607587

A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.

Monroe Biomedical Research, North Charleston

În curs de recrutareFaza 2

Vârste de la 18 la 60 · Toate sexele · Actualizat 22 iun. 2026 · NCT07570758

Efficacy of Center-based Childcare to Mitigate Unhealthy Weight Gain in Preschoolers From Low-income Households During the Summer

University of South Carolina, Columbia

În curs de recrutareVoluntari sănătoși bineveniți

Vârste de la 3 la 5 · Toate sexele · Actualizat 11 iun. 2026 · NCT07583459

Weight Loss and ExeRcise for Post-stroke Veterans

Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston

În curs de recrutare

Vârste de la 40 la 80 · Toate sexele · Actualizat 15 mai 2026 · NCT06322030

EMPOWER: Effects of Weight Loss and Exercise Post-stroke

College of Health Professions, Charleston

În curs de recrutare

Vârste de la 35 la 85 · Toate sexele · Actualizat 15 apr. 2026 · NCT05901675

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.